ST, looking at the possible competition in your post, it strikes me that none have their own QDX HealthID, a secure, anticounterfeiting blockchain database that reports health status (red, yellow, green) and gives the person tested the control over who sees their data.
Jay Williams said they would alpha test QDX HEALTHID in May and beta test both a test and HealthID in June, and we all think they want to sell both as a package, right? What is being used by those doing testing right now instead of QDX HealthID, a freestanding health status reporting DLT blockchain?
Hospital systems like Kaiser Permanente have their own client management system, which works for them, but clearly would not integrate with anyone else's system, such as retail, food processing, industrial, transportation, etc. Everyone is doing their own thing in testing and none are looking for synergies to reduce duplication of efforts.
Contact tracing has existed well before the first debt collection agency came into existence. QMC'S anticounterfeiting DLT is a product track and trace blockchain, but is designed to run without a lot manual work such as labor intensive contact tracing.
QMC dealt with the ethical questions of testing and contact tracing in the Atlantic Council webinar. For testing, QMC gives the control over who can see the test to the person being tested. QMC does not want the contract tracing business but makes the point that QDX HealthID could work with contact tracing software while maintaining client data security in an unhackable database. (The business plan is license and royalties NOT labour intensive contact tracing. QMC would leave that to others,) Further, if cities or states or companie all use QDX HealthID, all the records could be linked in one blockchain, and the person tested would still control his record and could travel between locations and their work and use the same test for proof of health status. The system is (infinitely?) expandable.
Ideally, QMC sells a system to test and record keep and generates multiple recurring revenue steams from the combination, but it could license any single part, such as it Quantum Dots anticounterfeiting labels, to other manufacturers. Fake tests do exist, and QR and bar codes can be counterfeited.
The number of tests in the USA that are given daily are close to peak manufacturing capability. The Atlantic reports today that most PCR test manufacturers are at their production limit, and/or cannot get supplies/parts for their tests. Antibody Testing companies could provide millions more tests weekly.
My point is not to ask why more tests are not available, but to mention that when they are available, they will all need a system like QDX HealthID to keep their test records safe. The more connected the tests, the more the users benefit. I think there is a tremendously large market to license QDX HealthID by itself to other test manufacturers.
Jay Williams said they would alpha test QDX HEALTHID in May and beta test both a test and HealthID in June, and we all think they want to sell both as a package, right? What is being used by those doing testing right now instead of QDX HealthID, a freestanding health status reporting DLT blockchain?
Hospital systems like Kaiser Permanente have their own client management system, which works for them, but clearly would not integrate with anyone else's system, such as retail, food processing, industrial, transportation, etc. Everyone is doing their own thing in testing and none are looking for synergies to reduce duplication of efforts.
Contact tracing has existed well before the first debt collection agency came into existence. QMC'S anticounterfeiting DLT is a product track and trace blockchain, but is designed to run without a lot manual work such as labor intensive contact tracing.
QMC dealt with the ethical questions of testing and contact tracing in the Atlantic Council webinar. For testing, QMC gives the control over who can see the test to the person being tested. QMC does not want the contract tracing business but makes the point that QDX HealthID could work with contact tracing software while maintaining client data security in an unhackable database. (The business plan is license and royalties NOT labour intensive contact tracing. QMC would leave that to others,) Further, if cities or states or companie all use QDX HealthID, all the records could be linked in one blockchain, and the person tested would still control his record and could travel between locations and their work and use the same test for proof of health status. The system is (infinitely?) expandable.
Ideally, QMC sells a system to test and record keep and generates multiple recurring revenue steams from the combination, but it could license any single part, such as it Quantum Dots anticounterfeiting labels, to other manufacturers. Fake tests do exist, and QR and bar codes can be counterfeited.
The number of tests in the USA that are given daily are close to peak manufacturing capability. The Atlantic reports today that most PCR test manufacturers are at their production limit, and/or cannot get supplies/parts for their tests. Antibody Testing companies could provide millions more tests weekly.
My point is not to ask why more tests are not available, but to mention that when they are available, they will all need a system like QDX HealthID to keep their test records safe. The more connected the tests, the more the users benefit. I think there is a tremendously large market to license QDX HealthID by itself to other test manufacturers.
